Cite
HARVARD Citation
Hricik, D. et al. (n.d.). Interferon Gamma ELISPOT Testing as a Risk‐Stratifying Biomarker for Kidney Transplant Injury: Results From the CTOT‐01 Multicenter Study. American journal of transplantation. 15 (12), pp. 3166-3173. [Online].